Neurocrine Biosciences (NBIX) Net Margin Growth (1y) (2011 - 2026)
Neurocrine Biosciences (NBIX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | -2,219.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -58.00 |
| Mar 31, 2026 | 2,292.00 |
| Dec 31, 2025 | 266.00 |
| Sep 30, 2025 | 549.00 |
| Jun 30, 2025 | 462.00 |
| Mar 31, 2025 | -704.00 |
| Dec 31, 2024 | -1,224.00 |
| Sep 30, 2024 | 420.00 |
| Jun 30, 2024 | -1,008.00 |
| Mar 31, 2024 | 2,664.00 |
| Dec 31, 2023 | 707.00 |
| Sep 30, 2023 | -100.00 |
| Jun 30, 2023 | 10,560.00 |
| Mar 31, 2023 | -2,270.00 |
| Dec 31, 2022 | 2,394.00 |
| Sep 30, 2022 | 1,006.00 |
| Jun 30, 2022 | -9,914.00 |
| Mar 31, 2022 | -909.00 |
| Dec 31, 2021 | -14,268.00 |
| Sep 30, 2021 | 2,988.00 |